Reviews Gonal-f RFF


No reviews yet.

Gonal-f RFF Drug Description
Gonal-f® RFF
(follitropin alfa) For Subcutaneous Injection
*revised formulation female
DRUG DESCRIPTION



What are the possible side effects of follicle stimulating hormone (Follistim, Follistim AQ, Gonal-F, Gonal-f RFF, Gonal-f RFF Pen)?

Stop using follicle stimulating hormone and seek emergency medical attention or notify your doctor immediately if you experience any of the following serious side effects:

an allergic reaction (difficulty breathing; closing of the throat; swelling of the lips, tongue, or face; or hives);
pain, warmth, redness, numbness, or tingling in an arm or leg (which may indicate a blood clot);
confusion, severe...
Read All Potential Side Effects for Gonal-f RFF »




Gonal-f® RFF (follitropin alfa for injection) is a human follicle stimulating hormone (FSH) preparation of recombinant DNA origin, which consists of two non-covalently linked, non-identical glycoproteins designated as the α- and β-subunits. The α- and β-subunits have 92 and 111 amino acids, respectively, and their primary and tertiary structure are indistinguishable from those of human follicle stimulating hormone. Recombinant FSH production occurs in genetically modified Chinese Hamster Ovary (CHO) cells cultured in bioreactors. Purification by immunochromatography using an antibody specifically binding FSH results in a highly purified preparation with a consistent FSH isoform profile, and a high specific activity. The biological activity of follitropin alfa is determined by measuring the increase in ovary weight in female rats. The in vivo biological activity of follitropin alfa has been calibrated against the first International Standard for recombinant human follicle stimulating hormone established in 1995 by the Expert Committee on Biological Standards of the World Health Organization. Gonal-f® RFF contains no luteinizing hormone (LH) activity. Based on available data derived from physico-chemical tests and bioassays, follitropin alfa and follitropin beta, another recombinant follicle stimulating hormone product, are indistinguishable.
Gonal-f® RFF is a sterile, lyophilized powder intended for subcutaneous injection after reconstitution.
Each Gonal-f® RFF single-dose vial is filled with 82 IU (6 µg)follitropin alfa to deliver 75 IU (5.5 µg) follitropin alfa and contains 30 mg sucrose, 1.11 mg dibasic sodium phosphate dihydrate, 0.45 mg monobasic sodium phosphate monohydrate, 0.1 mg methionine, and 0.05 mg polysorbate 20. Phosphoric acid and/or sodium hydroxide may be used prior to lyophilization for pH adjustment. Vials are reconstituted with Sterile Water for Injection, USP.
Under current storage conditions, Gonal-f® RFF may contain up to 10% of oxidized follitropin alfa.
Therapeutic Class: InfertilityLast reviewed on RxList: 7/26/2007




Gonal-f RFF Drug Description
Gonal-f® RFF
(follitropin alfa) For Subcutaneous Injection
*revised formulation female
DRUG DESCRIPTION



What are the possible side effects of follicle stimulating hormone (Follistim, Follistim AQ, Gonal-F, Gonal-f RFF, Gonal-f RFF Pen)?

Stop using follicle stimulating hormone and seek emergency medical attention or notify your doctor immediately if you experience any of the following serious side effects:

an allergic reaction (difficulty breathing; closing of the throat; swelling of the lips, tongue, or face; or hives);
pain, warmth, redness, numbness, or tingling in an arm or leg (which may indicate a blood clot);
confusion, severe...
Read All Potential Side Effects for Gonal-f RFF »




Gonal-f® RFF (follitropin alfa for injection) is a human follicle stimulating hormone (FSH) preparation of recombinant DNA origin, which consists of two non-covalently linked, non-identical glycoproteins designated as the α- and β-subunits. The α- and β-subunits have 92 and 111 amino acids, respectively, and their primary and tertiary structure are indistinguishable from those of human follicle stimulating hormone. Recombinant FSH production occurs in genetically modified Chinese Hamster Ovary (CHO) cells cultured in bioreactors. Purification by immunochromatography using an antibody specifically binding FSH results in a highly purified preparation with a consistent FSH isoform profile, and a high specific activity. The biological activity of follitropin alfa is determined by measuring the increase in ovary weight in female rats. The in vivo biological activity of follitropin alfa has been calibrated against the first International Standard for recombinant human follicle stimulating hormone established in 1995 by the Expert Committee on Biological Standards of the World Health Organization. Gonal-f® RFF contains no luteinizing hormone (LH) activity. Based on available data derived from physico-chemical tests and bioassays, follitropin alfa and follitropin beta, another recombinant follicle stimulating hormone product, are indistinguishable.
Gonal-f® RFF is a sterile, lyophilized powder intended for subcutaneous injection after reconstitution.
Each Gonal-f® RFF single-dose vial is filled with 82 IU (6 µg)follitropin alfa to deliver 75 IU (5.5 µg) follitropin alfa and contains 30 mg sucrose, 1.11 mg dibasic sodium phosphate dihydrate, 0.45 mg monobasic sodium phosphate monohydrate, 0.1 mg methionine, and 0.05 mg polysorbate 20. Phosphoric acid and/or sodium hydroxide may be used prior to lyophilization for pH adjustment. Vials are reconstituted with Sterile Water for Injection, USP.
Under current storage conditions, Gonal-f® RFF may contain up to 10% of oxidized follitropin alfa.
Therapeutic Class: InfertilityLast reviewed on RxList: 7/26/2007




Gonal-f RFF Drug Description
Gonal-f® RFF
(follitropin alfa) For Subcutaneous Injection
*revised formulation female
DRUG DESCRIPTION



What are the possible side effects of follicle stimulating hormone (Follistim, Follistim AQ, Gonal-F, Gonal-f RFF, Gonal-f RFF Pen)?

Stop using follicle stimulating hormone and seek emergency medical attention or notify your doctor immediately if you experience any of the following serious side effects:

an allergic reaction (difficulty breathing; closing of the throat; swelling of the lips, tongue, or face; or hives);
pain, warmth, redness, numbness, or tingling in an arm or leg (which may indicate a blood clot);
confusion, severe...
Read All Potential Side Effects for Gonal-f RFF »




Gonal-f® RFF (follitropin alfa for injection) is a human follicle stimulating hormone (FSH) preparation of recombinant DNA origin, which consists of two non-covalently linked, non-identical glycoproteins designated as the α- and β-subunits. The α- and β-subunits have 92 and 111 amino acids, respectively, and their primary and tertiary structure are indistinguishable from those of human follicle stimulating hormone. Recombinant FSH production occurs in genetically modified Chinese Hamster Ovary (CHO) cells cultured in bioreactors. Purification by immunochromatography using an antibody specifically binding FSH results in a highly purified preparation with a consistent FSH isoform profile, and a high specific activity. The biological activity of follitropin alfa is determined by measuring the increase in ovary weight in female rats. The in vivo biological activity of follitropin alfa has been calibrated against the first International Standard for recombinant human follicle stimulating hormone established in 1995 by the Expert Committee on Biological Standards of the World Health Organization. Gonal-f® RFF contains no luteinizing hormone (LH) activity. Based on available data derived from physico-chemical tests and bioassays, follitropin alfa and follitropin beta, another recombinant follicle stimulating hormone product, are indistinguishable.
Gonal-f® RFF is a sterile, lyophilized powder intended for subcutaneous injection after reconstitution.
Each Gonal-f® RFF single-dose vial is filled with 82 IU (6 µg)follitropin alfa to deliver 75 IU (5.5 µg) follitropin alfa and contains 30 mg sucrose, 1.11 mg dibasic sodium phosphate dihydrate, 0.45 mg monobasic sodium phosphate monohydrate, 0.1 mg methionine, and 0.05 mg polysorbate 20. Phosphoric acid and/or sodium hydroxide may be used prior to lyophilization for pH adjustment. Vials are reconstituted with Sterile Water for Injection, USP.
Under current storage conditions, Gonal-f® RFF may contain up to 10% of oxidized follitropin alfa.
Therapeutic Class: InfertilityLast reviewed on RxList: 7/26/2007




Gonal-f RFF Drug Description
Gonal-f® RFF
(follitropin alfa) For Subcutaneous Injection
*revised formulation female
DRUG DESCRIPTION



What are the possible side effects of follicle stimulating hormone (Follistim, Follistim AQ, Gonal-F, Gonal-f RFF, Gonal-f RFF Pen)?

Stop using follicle stimulating hormone and seek emergency medical attention or notify your doctor immediately if you experience any of the following serious side effects:

an allergic reaction (difficulty breathing; closing of the throat; swelling of the lips, tongue, or face; or hives);
pain, warmth, redness, numbness, or tingling in an arm or leg (which may indicate a blood clot);
confusion, severe...
Read All Potential Side Effects for Gonal-f RFF »




Gonal-f® RFF (follitropin alfa for injection) is a human follicle stimulating hormone (FSH) preparation of recombinant DNA origin, which consists of two non-covalently linked, non-identical glycoproteins designated as the α- and β-subunits. The α- and β-subunits have 92 and 111 amino acids, respectively, and their primary and tertiary structure are indistinguishable from those of human follicle stimulating hormone. Recombinant FSH production occurs in genetically modified Chinese Hamster Ovary (CHO) cells cultured in bioreactors. Purification by immunochromatography using an antibody specifically binding FSH results in a highly purified preparation with a consistent FSH isoform profile, and a high specific activity. The biological activity of follitropin alfa is determined by measuring the increase in ovary weight in female rats. The in vivo biological activity of follitropin alfa has been calibrated against the first International Standard for recombinant human follicle stimulating hormone established in 1995 by the Expert Committee on Biological Standards of the World Health Organization. Gonal-f® RFF contains no luteinizing hormone (LH) activity. Based on available data derived from physico-chemical tests and bioassays, follitropin alfa and follitropin beta, another recombinant follicle stimulating hormone product, are indistinguishable.
Gonal-f® RFF is a sterile, lyophilized powder intended for subcutaneous injection after reconstitution.
Each Gonal-f® RFF single-dose vial is filled with 82 IU (6 µg)follitropin alfa to deliver 75 IU (5.5 µg) follitropin alfa and contains 30 mg sucrose, 1.11 mg dibasic sodium phosphate dihydrate, 0.45 mg monobasic sodium phosphate monohydrate, 0.1 mg methionine, and 0.05 mg polysorbate 20. Phosphoric acid and/or sodium hydroxide may be used prior to lyophilization for pH adjustment. Vials are reconstituted with Sterile Water for Injection, USP.
Under current storage conditions, Gonal-f® RFF may contain up to 10% of oxidized follitropin alfa.
Therapeutic Class: InfertilityLast reviewed on RxList: 7/26/2007




Gonal-f RFF Drug Description
Gonal-f® RFF
(follitropin alfa) For Subcutaneous Injection
*revised formulation female
DRUG DESCRIPTION



What are the possible side effects of follicle stimulating hormone (Follistim, Follistim AQ, Gonal-F, Gonal-f RFF, Gonal-f RFF Pen)?

Stop using follicle stimulating hormone and seek emergency medical attention or notify your doctor immediately if you experience any of the following serious side effects:

an allergic reaction (difficulty breathing; closing of the throat; swelling of the lips, tongue, or face; or hives);
pain, warmth, redness, numbness, or tingling in an arm or leg (which may indicate a blood clot);
confusion, severe...
Read All Potential Side Effects for Gonal-f RFF »




Gonal-f® RFF (follitropin alfa for injection) is a human follicle stimulating hormone (FSH) preparation of recombinant DNA origin, which consists of two non-covalently linked, non-identical glycoproteins designated as the α- and β-subunits. The α- and β-subunits have 92 and 111 amino acids, respectively, and their primary and tertiary structure are indistinguishable from those of human follicle stimulating hormone. Recombinant FSH production occurs in genetically modified Chinese Hamster Ovary (CHO) cells cultured in bioreactors. Purification by immunochromatography using an antibody specifically binding FSH results in a highly purified preparation with a consistent FSH isoform profile, and a high specific activity. The biological activity of follitropin alfa is determined by measuring the increase in ovary weight in female rats. The in vivo biological activity of follitropin alfa has been calibrated against the first International Standard for recombinant human follicle stimulating hormone established in 1995 by the Expert Committee on Biological Standards of the World Health Organization. Gonal-f® RFF contains no luteinizing hormone (LH) activity. Based on available data derived from physico-chemical tests and bioassays, follitropin alfa and follitropin beta, another recombinant follicle stimulating hormone product, are indistinguishable.
Gonal-f® RFF is a sterile, lyophilized powder intended for subcutaneous injection after reconstitution.
Each Gonal-f® RFF single-dose vial is filled with 82 IU (6 µg)follitropin alfa to deliver 75 IU (5.5 µg) follitropin alfa and contains 30 mg sucrose, 1.11 mg dibasic sodium phosphate dihydrate, 0.45 mg monobasic sodium phosphate monohydrate, 0.1 mg methionine, and 0.05 mg polysorbate 20. Phosphoric acid and/or sodium hydroxide may be used prior to lyophilization for pH adjustment. Vials are reconstituted with Sterile Water for Injection, USP.
Under current storage conditions, Gonal-f® RFF may contain up to 10% of oxidized follitropin alfa.
Therapeutic Class: InfertilityLast reviewed on RxList: 7/26/2007





Other reviews about Gonal-f RFF on wordpress

The First Injection
  by melbagirl
Well. I sat very still with my skin pinched and an injection looming for at least ten minutes.ツ Maybe more.ツ Eventually I mustered up the guts to inject myself.ツ […]



Other reviews about Gonal-f RFF on web:

Learn about the prescription medication Gonal-f RFF (Follitropin Alfa Injection), drug uses, dosage, side effects, drug interactions, warnings, reviews and patient labeling. Gonal-f RFF (Follitropin Alfa Injection) Drug Information: Uses ...


Gonal-fテδづつョ RFF Pen (follitropin alfa injection) is used with Ovulation Induction to help ovaries make more eggs. Learn more at FertilityLifeLines.com. Gonal-fテδづつョ RFF Pen (follitropin alfa injection) - Fertility ...


The Gonal-fテδづつョ RFF 75 IU Vial is a prefilled syringe of diluent, eliminating an extra step of preparation for injection, that helps treat infertile patients not due to primary ... Gonal-fテδづつョ RFF 75 IU Vial - Fertility LifeLinesテδ「テつテつ「


Accurate, FDA approved Gonal-f RFF information for healthcare professionals and patients - brought to you by Drugs.com. Gonal-f RFF Official FDA information, side effects and uses.


Physician reviewed Gonal-f RFF (injectable) patient information - includes Gonal-f RFF description, dosage and directions. Gonal-f RFF (injectable) medical facts from Drugs.com


Follicle stimulating hormone (FSH) is a naturally occurring hormone. FSH is important in the development of follicles (eggs) produced by the ovaries. Gonal-f RFF Information - Drugs and Treatments - MedHelp


Gonal-F? RFF 75 IU Vials What is Gonal-F? RFF? Gonal-F? RFF (Revised Formulation Female) is a follicle stimulating hormone (FSH), one of the hormones that stimulates the ovary to ... Gonal-Fテδづつョ RFF 75 IU Vials


Gonal-f Gonal-f rff Gonal-f rff pen ... hello , first time on this site, but yes I've use gonal F without any side effects ... gonal f - Fertility - MedHelp


Information about Gonal-F RFF 900U/1.5 ml; Information about Gonal F RFF 300U/0.5 ml; Information about Gonal-F RFF 75 U; General Product Information About Gonal Gonal - On Sale by licensed US pharmacy!


Under current storage conditions, Gonal-fテδづつョ RFF may contain up to 10% of oxidized follitropin alfa. Therapeutic Class: Infertility. Last reviewed on RxList: 7/26/2007 Gonal-F (Follitropin Alfa) Drug Information: Uses, Side Effects ...





Featured Reviews

Reviews Voltaren Ophthalmic

Voltaren Ophthalmic Drug Description VOLTAREN OPHTHALMIC® (diclofenac sodium) Ophthalmic Solution 0.1% Sterile Ophthalmic Solution DRUG DESCRIPTION What are the possible side effects of diclofenac ophthalmic (Voltaren Ophthalmic)? Get...
Read More  |  Review This
Reviews Norgestimate and Ethinyl Estradiol Tablets

TriNessa Drug Description TriNessa™ (norgestimate and ethinyl estradiol tablets) Patients should be counseled that this product does not protect against HIV infection (AIDS) and other sexually transmitted diseases. DRUG DESCRIPTION ...
Read More  |  Review This
Reviews Hycamtin

Hycamtin Drug Description HYCAMTIN® (topotecan hydrochloride) for Injection WARNING BONE MARROW SUPPRESSION Do not give HYCAMTIN to patients with baseline neutrophil counts less than 1,500 cells/mm³. In order to monitor...
Read More  |  Review This
Reviews Carmustine

BiCNU Drug Description BiCNU (carmustine) For Injection WARNINGS BiCNU (carmustine for injection) should be administered under the supervision of a qualified physician experienced in the use of cancer chemotherapeutic agents....
Read More  |  Review This
Reviews Belladonna Alkaloids, Phenobarbital

Donnatal Extentabs Drug Description Donnatal Extentabs® (belladonna alkaoids, phenobarbital) DRUG DESCRIPTION What are the possible side effects of belladonna alkaloids and phenobarbital (Bellatal, Donnatal, D-Tal)? Get emergency...
Read More  |  Review This
Recent News
59sec - the BEST lead management system around!
We tested 59sec - THE lead management system and we love it. 59sec helps small and medium companies to answer leads in maximum 59 seconds. Why...
MOVEorPAY - our favorite facebook app
We do love MOVEorPAY motivational facebook app, because it is very cool and useful. It makes you finish stuff that you know are good for you, but from various reasons, you never do...
ReviewsAZ is almost ready to be officially launched
yes, we have just a few loose ends to tie and we are ready to go :) meanwhile, I am putting some reviews on the site, so people will not get an empty site at the launch....